PubRank
Search
About
RIBS V (Restenosis Intra-stent of Bare Metal Stents: Paclitaxel-eluting Balloon vs Everolimus-eluting Stent) (RIBS V)
Clinical Trial ID NCT01239953
PubWeight™ 0.94
‹?›
🔗 Visit the ClinicalTrials.gov page for NCT01239953
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study.
Lancet
2007
7.61
2
Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter.
N Engl J Med
2006
4.07
3
Three-year follow-up after implantation of metallic coronary-artery stents.
N Engl J Med
1996
2.95
4
Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome.
Circulation
1999
2.67
5
Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: a randomized trial.
JAMA
2008
2.59
6
Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial.
JAMA
2005
2.53
7
Sirolimus-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the SISR randomized trial.
JAMA
2006
2.16
8
Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis.
Circulation
2009
2.09
9
Paclitaxel-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the TAXUS V ISR randomized trial.
JAMA
2006
2.03
10
Cutting balloon versus conventional balloon angioplasty for the treatment of in-stent restenosis: results of the restenosis cutting balloon evaluation trial (RESCUT).
J Am Coll Cardiol
2004
1.77
11
A randomized comparison of sirolimus-eluting stent with balloon angioplasty in patients with in-stent restenosis: results of the Restenosis Intrastent: Balloon Angioplasty Versus Elective Sirolimus-Eluting Stenting (RIBS-II) trial.
J Am Coll Cardiol
2006
1.72
12
Midterm outcome of patients with asymptomatic restenosis after coronary balloon angioplasty.
J Am Coll Cardiol
1992
1.50
13
Geographic miss: a cause of treatment failure in radio-oncology applied to intracoronary radiation therapy.
Circulation
2000
1.48
14
Long-term results (three to five years) of the Restenosis Intrastent: Balloon angioplasty versus elective Stenting (RIBS) randomized study.
J Am Coll Cardiol
2005
1.48
15
Cutting balloon angioplasty for the treatment of in-stent restenosis: a matched comparison with rotational atherectomy, additional stent implantation and balloon angioplasty.
J Am Coll Cardiol
2001
1.48
16
Sirolimus-eluting stents versus bare-metal stents in patients with in-stent restenosis: results of a pooled analysis of two randomized studies.
Catheter Cardiovasc Interv
2008
1.46
17
Oral rapamycin after coronary bare-metal stent implantation to prevent restenosis: the Prospective, Randomized Oral Rapamycin in Argentina (ORAR II) Study.
J Am Coll Cardiol
2006
1.46
18
Five-year follow-up after intracoronary gamma radiation therapy for in-stent restenosis.
Circulation
2004
1.45
19
Everolimus-Eluting Stents in Patients With Bare-Metal and Drug-Eluting In-Stent Restenosis: Results From a Patient-Level Pooled Analysis of the RIBS IV and V Trials.
Circ Cardiovasc Interv
2016
1.40
20
Utility of the fractional flow reserve in the evaluation of angiographically moderate in-stent restenosis.
Eur Heart J
2004
1.12
21
A randomized comparison of drug-eluting balloon versus everolimus-eluting stent in patients with bare-metal stent-in-stent restenosis: the RIBS V Clinical Trial (Restenosis Intra-stent of Bare Metal Stents: paclitaxel-eluting balloon vs. everolimus-eluting stent).
J Am Coll Cardiol
2014
1.00
22
Rotational atherectomy does not reduce recurrent in-stent restenosis: results of the angioplasty versus rotational atherectomy for treatment of diffuse in-stent restenosis trial (ARTIST).
Circulation
2002
0.97
23
Early lumen loss after treatment of in-stent restenosis: an intravascular ultrasound study.
Circulation
1998
0.95
24
Effectiveness of drug-eluting stents in patients with bare-metal in-stent restenosis: meta-analysis of randomized trials.
J Am Coll Cardiol
2006
0.94
25
A randomized comparison of repeat stenting with balloon angioplasty in patients with in-stent restenosis.
J Am Coll Cardiol
2003
0.93
26
In-stent restenosis: the Washington Hospital Center experience.
Am J Cardiol
1998
0.92
27
Six-month angiographic outcome after successful repeat percutaneous intervention for in-stent restenosis.
Circulation
1998
0.91
28
Therapeutic implications of in-stent restenosis located at the stent edge. Insights from the restenosis intra-stent balloon angioplasty versus elective stenting (RIBS) randomized trial.
Eur Heart J
2004
0.91
29
Fate of stent-related side branches after coronary intervention in patients with in-stent restenosis.
J Am Coll Cardiol
2000
0.90
30
Mechanisms and results of balloon angioplasty for the treatment of in-stent restenosis.
Am J Cardiol
1996
0.87
31
Long-term clinical follow-up after successful repeat percutaneous intervention for stent restenosis.
J Am Coll Cardiol
1997
0.86
32
Treatment of in-stent restenosis with excimer laser coronary angioplasty versus rotational atherectomy: comparative mechanisms and results.
Circulation
2000
0.86
33
Treatment of patients with in-stent restenosis.
EuroIntervention
2009
0.83
34
Long-term clinical benefit of sirolimus-eluting stents in patients with in-stent restenosis results of the RIBS-II (Restenosis Intra-stent: Balloon angioplasty vs. elective sirolimus-eluting Stenting) study.
J Am Coll Cardiol
2008
0.82
35
Directional atherectomy for treatment of restenosis within coronary stents: clinical, angiographic and histologic results.
J Am Coll Cardiol
1992
0.81
36
Spanish Cardiac Catheterization and Coronary Intervention Registry. 17th official report of the Spanish Society of Cardiology Working Group on Cardiac Catheterization and Interventional Cardiology (1990-2007).
Rev Esp Cardiol
2008
0.81
37
Stenting the stent: initial results and long-term clinical and angiographic outcome of coronary stenting for patients with in-stent restenosis.
Am J Cardiol
2000
0.80
38
Value of the American College of Cardiology/American Heart Association angiographic classification of coronary lesion morphology in patients with in-stent restenosis. Insights from the Restenosis Intra-stent Balloon angioplasty versus elective Stenting (RIBS) randomized trial.
Am Heart J
2006
0.79
39
Randomized trial of Rotational Atherectomy Versus Balloon Angioplasty for Diffuse In-stent Restenosis (ROSTER).
Am Heart J
2004
0.77
40
New stent implantation for recurrences after stenting for in-stent restenosis: implications of a third metal layer in human coronary arteries.
J Am Coll Cardiol
2009
0.77
41
Implications of the "watermelon seeding" phenomenon during coronary interventions for in-stent restenosis.
Catheter Cardiovasc Interv
2005
0.77
42
Optimal implantation strategies using drug-eluting stents for in-stent restenosis: do we know the answer?
Circulation
2004
0.75
43
Intravascular ultrasound in patients with challenging in-stent restenosis: importance of precise stent visualization.
J Interv Cardiol
2006
0.75
44
Long-term outcome and determinants of event-free survival in patients treated with balloon angioplasty for in-stent restenosis.
Am J Cardiol
1999
0.75
45
Repeat stenting for the prevention of the early lumen loss phenomenon in patients with in-stent restenosis. Angiographic and intravascular ultrasound findings of a randomized study.
Am Heart J
2005
0.75
46
Drug-eluting stents and in-stent restenosis.
JAMA
2005
0.75
47
[Update on interventional cardiology].
Rev Esp Cardiol
2009
0.75
48
Stenting for coronary dissection after balloon dilation of in-stent restenosis: stenting a previously stented site.
Am Heart J
1996
0.75
49
Sirolimus-eluting stents vs brachytherapy for restenosis.
JAMA
2006
0.75
50
Should we use the cutting balloon in patients with in-stent restenosis?
J Am Coll Cardiol
2004
0.75
51
Long-Term Results of Everolimus-Eluting Stents Versus Drug-Eluting Balloons in Patients With Bare-Metal In-Stent Restenosis: 3-Year Follow-Up of the RIBS V Clinical Trial.
JACC Cardiovasc Interv
2016
0.75
Next 100